Syndax Pharmaceuticals Cash Flow Statement (2015-2026) | SNDX

Cash Flow Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-20.60M95.34M-38.19M-39.75M-35.11M-34.55M-45.92M-50.49M-51.47M-57.16M-81.24M-75.09M-84.16M-94.13M-84.57M-75.75M-60.46M-34.03M-42.44M-48.35M
Depreciation and Depletion (Quarter)
4.00M5.00M
Share-based Compensation (Quarter)
3.38M3.93M3.48M3.94M0.35M4.24M6.24M8.06M8.32M8.33M8.90M9.90M11.93M12.30M10.38M13.79M12.08M11.25M12.05M14.01M
Gains from Investment Securities (Quarter)
Cash from Operations (Quarter)
-24.94M100.71M-41.93M-40.31M-28.54M-22.89M-39.23M-35.37M-44.65M-41.35M-83.55M-71.64M-62.32M-57.39M-95.16M-87.80M-70.53M-69.49M-50.34M-30.27M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.17M-0.17M0.05M0.27M1.04M2.02M3.97M3.72M3.66M3.46M3.82M3.65M3.06M2.94M3.60M3.21M2.41M1.53M0.86M0.71M
Amortization of Deferred Charges (Quarter)
0.03M0.11M0.06M0.06M-0.00M0.06M0.30M
Depreciation & Amortization (CF) (Quarter)
4.00M5.00M
Change in Working Capital
Change in Receivables (Quarter)
8.56M4.54M2.08M-2.08M0.07M-0.07M6.07M3.51M-6.08M4.09M8.12M3.73M5.95M-11.37M-0.12M13.21M
Change in Inventory (Quarter)
0.37M4.19M12.92M7.18M7.80M2.06M-1.84M
Change in Account Payables (Quarter)
1.50M0.55M2.56M-1.79M0.68M-2.76M3.71M2.92M-4.93M3.91M-1.15M2.76M-6.67M6.73M-1.58M7.31M-3.53M2.75M-5.74M-5.97M
Change in Accured Expenses (Quarter)
1.90M0.64M3.86M-1.54M-3.86M10.97M-9.17M2.38M14.16M7.50M-6.71M-6.84M21.04M11.65M-2.53M17.90M1.10M25.70M-28.35M18.77M
Other Working Capital Changes (Quarter)
-0.89M-0.08M8.43M-3.50M2.74M-7.67M-2.90M2.44M0.46M2.85M-1.96M-1.35M-5.99M10.77M-4.78M14.54M-7.84M-1.39M
Investing Activities
Capital Expenditures (Quarter)
0.06M
Change in Acquisitions & Divestments (Quarter)
89.58M45.40M50.45M72.42M72.82M113.25M81.50M154.91M122.80M113.00M67.99M61.75M100.20M107.34M104.68M133.60M103.00M144.75M77.78M69.00M
Cash from Investing Activities (Quarter)
26.63M-59.96M8.18M-49.95M-6.79M-137.63M19.91M73.91M40.08M-16.29M-99.40M61.75M86.85M-268.97M94.14M41.89M72.43M81.58M38.39M-16.91M
Financing Activities
Other financing activities (Quarter)
0.10M6.09M0.09M2.61M7.36M1.44M0.20M3.23M1.59M0.11M0.31M0.24M0.54M0.63M0.55M-0.08M6.36M-5.29M7.46M8.76M
Cash from Financing Activities (Quarter)
1.71M109.78M0.56M21.72M-13.53M163.50M2.47M1.32M1.85M258.48M2.17M0.68M3.10M347.43M0.93M0.55M6.28M5.92M7.92M252.77M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
81.20M162.00M215.96M
Additional items
Change in Cash (Quarter)
3.39M150.53M-33.19M-68.53M-48.86M2.98M-16.84M39.86M-2.73M200.84M-180.78M-9.22M27.62M21.06M-0.09M-45.36M8.17M18.01M-4.04M205.58M
Free Cash Flow (Quarter)
-24.94M100.71M-41.93M-40.31M-28.54M-22.89M-39.23M-35.37M-44.65M-41.35M-83.55M-71.64M-62.32M-57.39M-95.16M-87.80M-70.53M-69.54M-50.34M-30.27M
Net Cash Flow (Quarter)
3.39M150.53M-33.19M-68.53M-48.86M2.98M-16.84M39.86M-2.73M200.84M-180.78M-9.22M27.62M21.06M-0.09M-45.36M8.17M18.01M-4.04M205.58M